Survival, Motor Function, and Motor Milestones: Comparison of AVXS-101 Relative to Nusinersen for the Treatment of Infants with Spinal Muscular Atrophy Type 1 Author Name Omar Dabbous et al Category Computer science, information & general works Type Journal Tags AVXS-101,Indirect treatment comparison,Nusinersen,Neuroscience,Onasemnogene abeparvovec,Spinal muscular atrophy type 1 (SMA type 1) Login to Access Content
